Is ANTX or APGE more undervalued in 2026?

CirclFi compares AN2 Therapeutics, Inc. (ANTX) and Apogee Therapeutics, Inc. (APGE) using 13 institutional-grade valuation models. ANTX has a Quality of Company score of 4.3/10 while APGE scores 4.2/10.

Which is a better buy — ANTX or APGE?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ANTX and APGE valuations compare?

ANTX at $4.46 and APGE at $77.82 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ANTX vs APGE Valuation Comparison 2026 — Intrinsic Value Analysis

ANTX

Biotechnology

AN2 Therapeutics, Inc.

Quality

4.3

out of 10

Value Trap

SAFE

Price

$4.46

Last close

Models

7/13

Active

APGE

Biotechnology

Apogee Therapeutics, Inc.

Quality

4.2

out of 10

Value Trap

SAFE

Price

$77.82

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	ANTX Fair Value	ANTX Upside	APGE Fair Value	APGE Upside
Bayesian DCF	Intrinsic	$2.01	-55.0%	$26.30	-66.2%
Earnings Power Value	Intrinsic	—	—	$37.75	-55.9%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.38	-91.4%	$5.69	-92.7%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ANTX vs APGE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ANTX vs APGE — Which Stock Is More Undervalued?

ANTX scores higher with a 4.3/10 quality rating vs APGE's 4.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing AN2 Therapeutics, Inc. (ANTX) and Apogee Therapeutics, Inc. (APGE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ANTX currently trades at $4.46 with a QOC of 4.3/10, while APGE trades at $77.82 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).